Grovix (accessible at https://bygrovix.com) is introducing an experimental monetization program that allows authors to earn revenue from their published articles. This feature is currently in testing and may evolve over time.
To be eligible for monetization, an author must publish at least five (5) articles within a period of three weeks. These articles must be of high quality and must comply with our Content and Copyright Policy. In addition, the author’s articles must collectively reach at least thirty thousand (30,000) unique readers within the same three-week period. Only after meeting these requirements may an author apply for monetization. Once approved, their account will be marked as verified and they will be able to monetize their articles.
Revenue generated from monetized articles will be shared between the author and Grovix. Authors will receive fifty-five percent (55%) of the earnings as their payout, while forty-five percent (45%) will be retained by Grovix to support platform operations and improvements. Authors will only see their earnings in their personal dashboard; the Grovix share will not be displayed.
Please note that this monetization program is experimental and may contain bugs or limitations. Our team reserves the right to review and reject any monetization applications at our sole discretion, even if the basic requirements are met. This ensures that content quality, community standards, and platform integrity are maintained at all times.
Currently, the Grovix monetization program is only available for users located in India. We may expand availability to other regions in the future as the program develops.
By applying for monetization, you acknowledge that you have read and agreed to this Monetization Policy in addition to our Terms and Conditions and Privacy Policy.